A pilot study on the off-label use of valproic acid to treat adenomyosis
article
OA: bronze
CC0
⤵ 62 in-corpus citations
AI-generated summary
This pilot study investigated the off-label use of valproic acid for adenomyosis and reported its findings.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (33)
- Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis via openalex
- Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis via openalex
- Adenomyosis: Not such an elusive diagnosis any longer via openalex
- Effect of the selective estrogen receptor modulator raloxifene on explanted uterine growth in rats via openalex
- Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780 via openalex
- Medical and surgical management of adenomyosis via openalex
- p16, retinoblastoma (pRb), and cyclin D1 protein expression in human endometriotic and adenomyotic lesions via openalex
- P-349 via openalex
- Pathophysiology of adenomyosis via openalex
- Persistence of dysmenorrhea and nonmenstrual pain after optimal endometriosis surgery may indicate adenomyosis via openalex
- Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Endometriosis via openalex
- The symptomatology of adenomyosis via openalex
- Treatment of adenomyosis with long-term GnRH analogues: a case report. via openalex
- Validation of Rat Endometriosis Model by Using Raloxifene as a Positive Control for the Evaluation of Novel SERM Compounds via openalex
- W2123883580 via openalex
- W2138154283 via openalex
- W6602921218 via openalex
- W6607491137 via openalex
- W72984541 via openalex
- W6635703387 via openalex
- W1601632081 via openalex
- W1935963841 via openalex
- W1964363319 via openalex
- W1975220342 via openalex
- W2001699192 via openalex
- W2006785548 via openalex
- W2015834221 via openalex
- W2038354928 via openalex
- W2086990722 via openalex
- W2098249941 via openalex
- W2098596663 via openalex
- W2105497865 via openalex
- W2117691193 via openalex
Cited by (50)
- Drug development for adenomyosis based on pathophysiology 2025
- Adenomyosis: Unravelling the causes and exploring treatment strategies among patients seeking conception 2025
- Consider fertility-preserving medications when treating adenomyosis 2024
- Meclizine improves endometrial repair and reduces simulated menstrual bleeding in mice with induced adenomyosis 2024
- Evaluation of Endpoints Used in Clinical Trials on Adenomyosis - ASystematic Review 2023
- The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review 2023
- Genetics and genomics of endometriosis☆ 2023
- Aberrant expression of histone deacetylase 8 in endometriosis and its potential as a therapeutic target 2023
- Hypercoagulability in women with adenomyosis who experience heavy menstrual bleeding 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis 2023
- Medical Treatment of Adenomyosis 2022
- Endometriosis Research: From Bench to Bedside 2022
- Insights on Adenomyosis Development 2022
- Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology 2022
- An Update on the Various Theories of the Origin of Uterine Adenomyosis –A Systematic Review 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis 2019
- The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights 2019
- The role of oxytocin in the pathogenesis of endometriosis: various aspects of the problem 2019
- Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology 2019
- Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going? 2019
- Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis 2018
- Investigational drugs for the treatment of endometriosis, an update on recent developments 2018
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? 2018
- Current and emerging treatment options for endometriosis 2018
- Genetics and Genomics of Endometriosis 2018
- Pathogenesis of adenomyosis: an update on molecular mechanisms 2017
- Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal et perspectives thérapeutiques 2017
- Revisiting the wandering womb: Oxytocin in endometriosis and bipolar disorder 2017
- Leonurine Attenuates Hyperalgesia in Mice with Induced Adenomyosis 2017
- Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence 2016
- Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis 2016
- Ali Farid’s Updated Innovation in Women Reproduction 2016
- Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis 2016
- Novel Medical Treatment Modalities of Endometriosis 2015
- On-label and off-label drug use in the treatment of endometriosis 2015
- An overview of early drug development for endometriosis 2015
- Potential New Drugs for Endometriosis: Experimental Evidence 2014
- Potential Mechanisms of an Antiadenomyosis Chinese Herbal Formula Shaoyao‐Gancao Decoction in Primary Cell Culture Model 2014
- Medical Treatments for Endometriosis-Associated Pelvic Pain 2014
- A pilot study on the use of andrographolide to treat symptomatic adenomyosis 2014
- Aberrant histone modification in endometriosis 2014
- Консенсус по ведению эндометриоза 2013
- Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells 2013
- Consensus on current management of endometriosis 2013
- Consensus on current management of endometriosis 2013
- Histone deacetylase inhibitors as therapeutics for endometriosis 2012
- Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis 2012
- Elevated Immunoreactivity against Class I Histone Deacetylases in Adenomyosis 2012
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:06.633332+00:00
License: CC0
· commercial use OK